Phase 2 Durvalumab Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)
Intrahepatic Cholangiocarcinoma (Icc)HAICDurvalumab
West China Hospital25 enrolled1 locationNCT06859684
Recruiting
Phase 2
Proton Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
HCC - Hepatocellular CarcinomaDurvalumabTremelimumab+1 more
Chang Gung Memorial Hospital45 enrolled1 locationNCT06999694
Recruiting
Phase 2
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
RadiotherapyHCC - Hepatocellular CarcinomaDurvalumab+1 more
Chang Gung Memorial Hospital45 enrolled1 locationNCT06999707